Angela Corona, PhD
Director, Business Development
Dr. Corona brings scientific and business expertise in a diverse range of life sciences and drug development fields. She has demonstrated success in directing non-dilutive funding strategy to secure substantial funds for multiple BioMotiv portfolio companies, along with conducting market and commercial analyses for new opportunities and building strategic collaborations to promote the success of early stage therapeutics projects. Dr. Corona leads the funding initiatives for SapVax, LLC.
Dr. Corona was a Post-doctoral Research Fellow in the Alzheimer’s Disease Research Laboratory at Case Western Reserve University in Cleveland, OH where she studied the molecular and cellular biology of neurodegenerative diseases and aging with a focus on regulation of microglia, lipid metabolism, and psychiatric dysfunction in mouse models of disease. For this work she was awarded a Ruth L. Kirschstein National Research Service Award from the NIH. Her work is published in more than a dozen primary research and review articles and has been presented at multiple international conferences.
Dr. Corona completed her Ph.D. in Neuroscience at the Ohio State University and holds a B.S. in Biochemistry from Binghamton University.